Elimination of Early Rehospitalization in a Randomized, Controlled Trial of Multidisciplinary Care in a High-Risk, Elderly Heart Failure Population: The Potential Contributions of Specialist Care, Clinical Stability and Optimal Angiotensin-Converting Enzyme Inhibitor Dose at Discharge

Abstract

Critical contributors to this improvement appear to be specialist cardiology care, adherence to clinical stability criteria prior to discharge and routine use of target or high-dose ACE inhibitor therapy prior to discharge. Widespread application of this approach may have a dramatic improvement in morbidity of CHF while limiting the escalating costs of this condition.